← Evidence map

ArticleOphthalmology and therapy2019

Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification.

Melissa M ToyosPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 30868419